EP2662091
And-P-selektín-mótefni og aðferðir til notkunar á þeim til að meðhöndla bólgusjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.11.2007EP published:
22.8.2018EP application number:
13164403.1
EP translation filed:
21.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
29.11.2027Expiry date:
29.11.2026Next due date:
30.11.2026
Title:
Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
Timeline
Today
30.11.2007EP application
22.8.2018EP Publication
21.11.2018Translation submitted
15.12.2018Registration published
29.11.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Name:
OklahomaMedical Research FoundationAddress:
825 N.E. 13th Street, 73104, Oklahoma City, OK, US
Inventor
Name:
McEver, Rodger P.Address:
Oklahoma City, OK, US
Name:
Alvarez, RichardAddress:
Edmond, OK, US
Name:
Kawar, ZiadAddress:
Oklahoma City, OK, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
872170 PDate:
1.12.2006Country:
US
Supplementary protection
SPC number:
SPC332
Classification
Categories:
A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 21.11.2018
Expires: 29.11.2019
Payer: Árnason Faktor
Number: 13
Paid: 24.10.2019
Expires: 29.11.2020
Payer: Árnason Faktor
Number: 14
Paid: 27.10.2020
Expires: 29.11.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 27.10.2021
Expires: 29.11.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 27.10.2022
Expires: 29.11.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.11.2023
Expires: 29.11.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.10.2024
Expires: 29.11.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 19.11.2025
Expires: 29.11.2026
Payer: Árnason Faktor ehf.